Acquired Hemophilia A After Nivolumab Therapy in a Patient With Metastatic Squamous Cell Carcinoma of the Lung Successfully Managed With Rituximab. uri icon

Overview

publication date

  • June 26, 2019

Research

keywords

  • Antineoplastic Agents, Immunological
  • Carcinoma, Squamous Cell
  • Drug-Related Side Effects and Adverse Reactions
  • Hemophilia A
  • Immunotherapy
  • Lung Neoplasms
  • Nivolumab
  • Rituximab

Identity

Scopus Document Identifier

  • 85068820916

Digital Object Identifier (DOI)

  • 10.1016/j.cllc.2019.06.022

PubMed ID

  • 31311716

Additional Document Info

volume

  • 20

issue

  • 5